Monday, June 22, 2026 · Covering: Fri–Mon
TL;DR
The weekend's biggest story isn't a deal — it's the Iran ceasefire fraying: Iran closed the Strait of Hormuz again on Saturday after Israeli strikes in Lebanon, oil jumped toward $78–81/bbl, and futures opened lower Monday. On the deal front, Fox Corp agreed to buy Roku for $22B to bolt streaming onto its broadcast business, Swedish PE firm EQT is taking UK testing giant Intertek private for $14.5B, and a defense-robotics startup is going public via a $1.5B reverse merger. Markets head into a pivotal inflation print this week still digesting a hawkish Fed.
TOP 3 DEALS
DEAL 01
Tech / Media (TMT)
TRANSACTION VALUE~$22B enterprise value; $160.00/share
CONSIDERATION$96.00 cash + 0.9693 FOX Class A shares per Roku share
FOX ADVISORSMorgan Stanley + Goldman Sachs (financial); Weil, Gotshal & Manges (legal)
ROKU ADVISORSQatalyst Partners (financial); Goodwin Procter (legal)
ANNOUNCEDJune 15, 2026
EXPECTED CLOSEH1 2027
Fox is buying Roku, the dominant connected-TV operating system with relationships in 100M+ streaming households, to pair with its own sports/news content and its Tubi streaming service. The deal is structured as part-cash, part-stock, and Morgan Stanley is also providing a $12B bridge loan to help Fox fund the cash portion — a sign of how much debt financing underpins even strategic (not just sponsor-led) deals today. Fox expects roughly $400M in annual cost synergies. CBS News ↗
Why it matters for recruiting: This is "vertical integration" in media — a content owner buying the distribution platform that delivers its content, rather than buying a competitor. Be ready to discuss the strategic logic (owning the "pipe" gives Fox first-party viewer data and ad inventory it doesn't control today) versus the risk (regulators scrutinizing platform-plus-content combinations). Also notice the financing structure: a bridge loan from the buyer's own advisor (Morgan Stanley) is common — banks often provide financing AND advice on the same deal, which is itself a topic worth understanding (potential conflicts, "advisory + financing" revenue stacking).
DEAL 02
Industrials / Business Services
TRANSACTION VALUE~$14.5B (£10.9B) incl. debt; £61.08/share cash
PREMIUM40% to last close; 62% to pre-approach price
EQT ADVISORSMorgan Stanley, Barclays, Deutsche Bank
INTERTEK ADVISORSJPMorgan, Goldman Sachs, PJT Partners
ANNOUNCEDJune 18, 2026
STRUCTUREAll-cash take-private (LBO)
Intertek tests, inspects, and certifies products and supply chains for manufacturers and governments in 100+ countries — a steady, recurring-revenue business that's exactly the kind of asset private equity loves to lever up. EQT is paying a hefty 62% premium to where the stock traded before its approach leaked, underscoring how much sponsors are willing to pay for "boring," cash-generative businesses right now. Three advisors on each side reflects the deal's size and the multiple workstreams (financing, fairness opinion, sale process) running in parallel. Global Banking & Finance ↗
Why it matters for recruiting: Textbook leveraged buyout: a financial sponsor (EQT) buys a stable cash-flow business and funds the purchase mostly with debt, planning to pay it down with the company's own cash flow and eventually sell or IPO it for a return. Know why test/certification/inspection ("TIC") businesses are popular LBO targets: high recurring revenue, low capex, sticky customer relationships — the same characteristics you'd screen for when building an LBO model. With three banks per side, this is also a good example of "two banks for execution, one for a second opinion" syndicate structuring.
DEAL 03
Defense / Tech
TRANSACTION VALUE$1.5B implied value (all-stock)
OWNERSHIP SPLITXTEND holders ~70% / JFB holders ~30% of new "XTEND AI Robotics"
XTEND ADVISORSStifel (financial); Paul Hastings + Meitar (legal)
JFB ADVISORSAdvisors TBD
ANNOUNCEDWeek of June 15, 2026
EXPECTED CLOSEMid-2026
XTEND, an Israeli-founded software company building an AI operating system for autonomous drones and defense robotics, is going public by merging into JFB Construction Holdings, a small already-listed construction company — effectively using JFB's Nasdaq ticker as a public "shell" rather than running a traditional IPO. The combined company, XTEND AI Robotics, will be majority-owned by XTEND's existing shareholders, with backers including Eric Trump and drone maker Unusual Machines. Pulse2 ↗
Why it matters for recruiting: This is a "reverse merger" — a private company (XTEND) merges into a small existing public company (JFB) to become publicly traded without a traditional IPO roadshow. It's mechanically similar to a SPAC merger but uses an operating shell instead of a blank-check company. Worth knowing the tradeoff: reverse mergers are faster and avoid IPO underwriting fees, but typically come with less price discovery and a smaller, less liquid investor base at first. Also a good example of capital chasing the defense-tech boom — strategic individual investors (not just VCs) are now writing checks into this space.
SECTOR SIGNAL
DEFENSE / AEROSPACE
Beyond the XTEND deal above, defense startup VC funding hit an all-time record in 2026 at $14.6B, up from $9.6B in 2025, as the Pentagon actively courts venture capital. Anduril remains the bellwether at a $30.5B valuation. Crunchbase ↗
TECH / TMT
Trump announced Apple will partner with Intel on US chip design and manufacturing, sending Intel up 10.6% and the broader semiconductor index up 6.4% — a reminder that industrial policy, not just M&A, is now moving tech stocks. TS2 ↗ Separately, a BlackRock/MGX/Nvidia/Microsoft/xAI consortium's ~$40B purchase of Aligned Data Centers remains the largest live AI-infrastructure deal in market. Data Center Frontier ↗
INDUSTRIALS
The EQT/Intertek take-private (Deal 02) headlines a broader trend: PE sponsors are paying steep premiums for "boring," recurring-revenue industrial services businesses, betting that stable cash flow can support heavy leverage even with rates higher for longer. MarketScreener ↗
HEALTHCARE / OTHER
Merck closed its roughly $10B acquisition of Verona Pharma, adding the COPD drug Ohtuvayre to its portfolio as it diversifies beyond Keytruda ahead of that drug's patent expiration later this decade — a live example of the "patent cliff" dynamic driving pharma M&A. Merck ↗
M&A / LEVERAGED FINANCE
Geopolitical risk just became a live variable in deal underwriting again: with Iran's Strait of Hormuz closure threatening oil flows, expect leveraged-loan and high-yield desks to watch oil-sensitive credits closely this week. Sponsors pricing new LBO debt (like EQT's Intertek financing) into a higher-for-longer rate environment plus oil-driven inflation risk face a tougher cost-of-capital picture than just two weeks ago. Wikipedia ↗
MARKET TONE
Iran ceasefire is fraying. Iran's military shut the Strait of Hormuz again on Saturday, calling it a response to a "clear breach" after Israeli strikes in Lebanon killed dozens post-ceasefire. Trump posted that the US — not Iran — should be "entitled" to any tolls on Hormuz passage. Pakistan is mediating new talks in Switzerland that began Sunday. Al Jazeera ↗
Oil spiked on the news. WTI crude jumped almost 3% toward $78/bbl and Brent climbed above $81/bbl as traders priced in renewed Hormuz disruption risk — the strait carries a large share of global seaborne oil. Bloomberg ↗
US futures opened lower Monday. S&P 500 futures slipped ~0.4%, Nasdaq 100 futures fell ~0.6%, and Dow futures were down ~0.3% as investors weighed the Iran headlines against a pivotal inflation report due later this week. Yahoo Finance ↗
Markets still digesting last week's hawkish Fed. New Chair Kevin Warsh's first FOMC meeting (June 17) held rates at 3.50–3.75% but flipped the dot plot toward a hike later this year, lifting the 10-year Treasury to roughly 4.46%. Futures markets are pricing zero cuts in 2026. Fox Business ↗
Credit markets still calm — for now. High-yield spreads remain contained around 278bps even with oil volatility and rate uncertainty stacking up, but a sustained Hormuz disruption or a hot inflation print this week could quickly change that calculus for leveraged issuers. Trading Economics ↗
INTERVIEW ANGLE
TOPIC: HOW GEOPOLITICAL SHOCKS FLOW THROUGH TO DEAL FINANCING
This weekend is a useful live case for a question interviewers love: "How does a geopolitical event affect M&A?" The Iran/Strait of Hormuz situation gives you a clean chain of logic to walk through, rather than a vague "macro is bad" answer.
Step 1 — commodity shock: A disruption to the Strait of Hormuz threatens oil supply, pushing crude prices up (WTI +3% this weekend alone).
Step 2 — inflation expectations rise: Higher energy prices feed directly into headline inflation, which is especially sensitive right now given the Fed just flipped hawkish on its own dot plot.
Step 3 — rates stay higher for longer: If the Fed has to fight oil-driven inflation, expect fewer (or no) rate cuts — bad news for anyone financing a deal with floating-rate leveraged loans, like EQT's Intertek buyout.
Step 4 — cost of debt rises, deal economics tighten: Higher base rates plus possible credit-spread widening directly compress the returns a sponsor can underwrite, which can slow announced-but-not-closed LBOs or push sponsors toward equity-heavier structures.
How to bring it up: If asked about current events, say: "I've been tracking how the Strait of Hormuz tensions this weekend could ripple into leveraged finance — oil-driven inflation risk complicates the Fed's hawkish pivot from last week, which raises the cost of debt for sponsors underwriting new LBOs like EQT's $14.5B Intertek deal." This shows you can connect a headline to deal mechanics instead of just reciting the news.